Found: 12
Select item for more details and to access through your institution.
Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy.
- Published in:
- Pharmacology Research & Perspectives, 2022, v. 10, n. 3, p. 1, doi. 10.1002/prp2.949
- By:
- Publication type:
- Article
Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation sensitivity by liquid -heating.
- Published in:
- Vox Sanguinis, 2012, v. 102, n. 2, p. 93, doi. 10.1111/j.1423-0410.2011.01523.x
- By:
- Publication type:
- Article
Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters.
- Published in:
- Vox Sanguinis, 2008, v. 95, n. 2, p. 94, doi. 10.1111/j.1423-0410.2008.01078.x
- By:
- Publication type:
- Article
Variability of parvovirus B19 to inactivation by liquid heating in plasma products.
- Published in:
- Vox Sanguinis, 2007, v. 92, n. 2, p. 121, doi. 10.1111/j.1423-0410.2006.00879.x
- By:
- Publication type:
- Article
Novel polymorphisms in the βig-h3 gene.
- Published in:
- Journal of Human Genetics, 1998, v. 43, n. 3, p. 214, doi. 10.1007/s100380050075
- By:
- Publication type:
- Article
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease.
- Published in:
- Cardiovascular Therapeutics, 2020, p. 1, doi. 10.1155/2020/9397109
- By:
- Publication type:
- Article
Reliability and validity of Japanese version of the McGill Quality of Life Questionnaire assessed by application in palliative care wards.
- Published in:
- Palliative Medicine, 2009, v. 23, n. 7, p. 659, doi. 10.1177/0269216309106875
- By:
- Publication type:
- Article
Heat sensitivity of human parvovirus B19.
- Published in:
- 2003
- By:
- Publication type:
- Erratum
Heat sensitivity of human parvovirus B19.
- Published in:
- Vox Sanguinis, 2003, v. 84, n. 3, p. 164, doi. 10.1046/j.1423-0410.2003.00280.x
- By:
- Publication type:
- Article
Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0696-z
- By:
- Publication type:
- Article
Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2683, doi. 10.3390/biomedicines11102683
- By:
- Publication type:
- Article
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1663, doi. 10.3390/biomedicines11061663
- By:
- Publication type:
- Article